Atlas Arteria Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Hugh Wehby

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	3.3yrs
Promedio de permanencia en la Junta Directiva	1.5yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Hugh Wehby (40 yo)

no data

Permanencia

Mr. Hugh Wehby, BEc (Hons), DipInvRel, has been the Chief Executive Officer, Managing Director and Director of Atlas Arteria Limited since November 18, 2024. He was Chief Commercial Officer of Transurban G...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
David Collins	Chief Financial Officer	2.3yrs	AU$1.18m	0.00073% A$ 51.7k
Vincent Portal-Barrault	Chief Operating Officer	5.6yrs	AU$1.59m	0.0079% A$ 561.4k
Hugh Wehby	CEO, MD & Director	no data	sin datos	sin datos
Tess Palmer	Director of Investor Relations	no data	sin datos	sin datos
Clayton McCormack	Company Secretary & General Counsel	5.6yrs	sin datos	sin datos
Navleen Prasad	Public Affairs Manager	no data	sin datos	sin datos
Jim Dickson	Corporate Development & Strategy Executive	no data	sin datos	sin datos
Catherine Brain	Group Executive of People & Culture	no data	sin datos	sin datos
Paul Lynch	Joint Company Secretary	3.3yrs	sin datos	sin datos
Ryan Reynolds	Specialist of Forecasting and Analysis	no data	sin datos	sin datos

3.3yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de ALX se considera experimentado (3.3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Hugh Wehby	CEO, MD & Director	no data	sin datos	sin datos
Jean-Georges Malcor	Independent Non-Executive Director	6yrs	AU$185.00k	0.0031% A$ 222.3k
David Bartholomew	Independent Non Executive Director	6.1yrs	AU$185.00k	0.0022% A$ 154.3k
Laura Hendricks	Independent Non-Executive Director	1.1yrs	AU$39.37k	sin datos
Debra Goodin	Independent Non-Executive Chairman	7.2yrs	AU$310.00k	0.0067% A$ 473.7k
Kiernan Bell	Independent Non-executive Director	1.2yrs	sin datos	0.00021% A$ 14.9k
Danny Elia	Non-Executive Director	less than a year	sin datos	sin datos
John Wigglesworth	Independent Non-Executive Director	1.8yrs	AU$185.00k	0.0019% A$ 137.4k
Kenneth Daley	Non-Executive Director	1.5yrs	AU$91.61k	0.00069% A$ 48.9k

1.5yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de ALX no se considera experimentada (1.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.

Atlas Arteria Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

High number of new directors

Atlas Arteria Limited Appoints Hugh Wehby as Managing Director

Atlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing Director

Atlas Arteria Limited, Annual General Meeting, May 15, 2024

Atlas Arteria Limited, Annual General Meeting, May 16, 2024

Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive Director

Recent updates

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

First half 2024 earnings released: EPS: AU$0.099 (vs AU$0.12 in 1H 2023)

Atlas Arteria Limited Appoints Hugh Wehby as Managing Director

Atlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025

Final dividend of AU$0.20 announced

Atlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024

Atlas Arteria Limited, Annual General Meeting, May 15, 2024

Atlas Arteria Limited, Annual General Meeting, May 16, 2024

Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)

Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Payable on 5 October 2023

First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)

Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023

Atlas Arteria Limited to Report First Half, 2024 Results on Aug 29, 2024

Atlas Arteria Limited Appoints Ken Daley as Director

Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023

Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)

Insufficient new directors

Atlas Arteria Limited Announces Board Changes

Atlas Arteria Limited (ASX:ALX) completed the acquisition of 66.67% stake in Skyway Concession Company, LLC from CPP Investments and OMERS Infrastructure.

Now 20% undervalued after recent price drop

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2023

Atlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023

Investor sentiment deteriorated over the past week

Atlas Arteria Limited Provides Distribution Guidance for the Year 2023

Atlas Arteria Limited (ASX:ALX) entered into an agreement to acquire a 66.67% stake in Skyway Concession Company, LLC for $2 billion.

First half 2022 earnings released: EPS: AU$0 (vs AU$0.074 in 1H 2021)

Atlas Arteria Limited Provides Dividend Guidance for the First Half of 2022

Investor sentiment improved over the past week

Atlas Arteria Limited Announces Executive Changes

Independent Non-Executive Director recently bought AU$76k worth of stock

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Insider recently bought AU$67k worth of stock

First half 2021 earnings released: EPS AU$0.074 (vs AU$0.14 loss in 1H 2020)

Independent Chairman of the Board recently bought AU$100k worth of stock

Full year 2020 earnings released: AU$0.061 loss per share (vs AU$0.024 profit in FY 2019)

Revenue misses expectations

Atlas Arteria Limited Announces Board Changes

New 90-day low: AU$6.00

Atlas Arteria Limited to Report Fiscal Year 2020 Results on Feb 25, 2021

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2021

Atlas Arteria Limited Announces Changes to its Board

New 90-day low: AU$5.95

New 90-day low: AU$6.10

New 90-day low - AU$6.11

Atlas Arteria Limited (ASX:ALX) acquired 6.14% stake in APRR and ADALEC from Macquarie European Infrastructure Fund II managed by Macquarie Infrastructure and Real Assets (Europe) Limited.

Earnings released

Atlas Arteria Limited has completed a Follow-on Equity Offering in the amount of AUD 74.999999 million.

CEO

Permanencia

Equipo directivo

Permanencia media

Miembros de la Junta

Permanencia media

Promedio de edad